Search - tctmd.com

Displaying 361 - 380 of 532

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Presenter: Anthony N. DeMaria, Allan Schwartz, Scott Lim

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

News Daily News

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

L.A. McKeown

June 19, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

News Daily News

FDA Advisory Panel Gives Thumbs Up to EVAR System

Todd Neale

June 14, 2018

News Industry News

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

June 13, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

News Daily News

Medical Device R&D Dropped by $34 Million Following Introduction of Controversial Excise Tax

Yael L. Maxwell

June 11, 2018

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Caitlin E. Cox

June 07, 2018

Podcast TCTMD Talking Points

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

June 06, 2018

News Daily News

Silent A-fib That Progresses Signals a Higher Heart Failure Risk

Todd Neale

June 06, 2018

News Daily News

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

Michael O'Riordan

June 05, 2018

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

Advertisement

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

FDA Advisory Panel Gives Thumbs Up to EVAR System

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

New European Hypertension Guidelines Not in Harmony With US Guidance

Medical Device R&D Dropped by $34 Million Following Introduction of Controversial Excise Tax

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Silent A-fib That Progresses Signals a Higher Heart Failure Risk

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

Class I Recall for Medtronic’s HeartWare HVAD System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content